IPCA LABORATORIES LTD. - Ipca and Oncobiologics Create Strategic Biosimilars Partnership

Ipca Laboratories Ltd has informed BSE that the Company has entered into an alliance with Oncobiologics, Inc., USA for the development, manufacture and commercialization of biosimilar monoclonal antibody products. The biologics covered under this alliance are among the most popular therapies in the world for immunology and oncology disease indications.<br/><br/>In this regard, the Company has issued a Press Relelase dated June 02, 2014 titled "Ipca and Oncobiologics Create Strategic Biosimilars Partnership".